Some Novaphos snippets, page-63

The second part of your comment may well be valid but I contest Avenira has neither the wherewithal or the financial horsepower to ever realise the technology as faulty as it may be.

IF, and a big IF, there is a new entrant of an equity players they will ensure current shareholders are diminished to being of no impact to their intent so being a shareholders right now is fraught with risk.

There is a solution for AEV and it isn't one of waxing lyrical of what could be as is done so often by others in here.

IHP as a phosphate processing technology is beyond the reach of AEV now and that initiative was lost years ago. The capital cost alone sinks it let alone the current governance capability and reputation. The current board know this and most informed operators in the industry know and no-one will play with the company whilst it is in the current hands, so AEV is uninvestable whilst the dream continues to be hung on to by the precious few.